Skip to content
10-K

Annual Report

ALDER BIOPHARMACEUTICALS INC

0001564590-19-004084

← back to feed
Filed
Feb 25, 2019 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Feb 22, 2019 68.5M sh
Capex FY 2018 · Dec 31, 2018 $3.14M
Capex FY 2018 · Dec 31, 2017 $2.05M
Capex FY 2018 · Dec 31, 2016 $6.62M
Operating Cash Flow FY 2018 · Dec 31, 2018 −$250.85M
Operating Cash Flow FY 2018 · Dec 31, 2017 −$226.62M
Operating Cash Flow FY 2018 · Dec 31, 2016 −$159.69M
Long Term Debt FY 2018 · Dec 31, 2018 $182.1M
Cash And Equivalents FY 2018 · Dec 31, 2018 $87.87M
Cash And Equivalents FY 2018 · Dec 31, 2017 $76.9M
Stockholders Equity FY 2018 · Dec 31, 2018 $109.98M
Stockholders Equity FY 2018 · Dec 31, 2017 $279.28M
Stockholders Equity FY 2018 · Dec 31, 2016 $382.78M
Stockholders Equity FY 2018 · Dec 31, 2015 $387.52M
Current Liabilities FY 2018 · Dec 31, 2018 $28.24M
Current Liabilities FY 2018 · Dec 31, 2017 $23.37M
Total Liabilities FY 2018 · Dec 31, 2018 $212.51M
Total Liabilities FY 2018 · Dec 31, 2017 $23.86M
Current Assets FY 2018 · Dec 31, 2018 $419.81M
Current Assets FY 2018 · Dec 31, 2017 $287.25M
Total Assets FY 2018 · Dec 31, 2018 $426.24M
Total Assets FY 2018 · Dec 31, 2017 $303.14M
Sga Expense FY 2018 · Dec 31, 2018 $47.47M
Sga Expense FY 2018 · Dec 31, 2017 $38.1M
Sga Expense FY 2018 · Dec 31, 2016 $26.15M
Rd Expense FY 2018 · Dec 31, 2018 $239.11M
Rd Expense FY 2018 · Dec 31, 2017 $252.9M
Rd Expense FY 2018 · Dec 31, 2016 $132.76M
Net Income FY 2018 · Dec 31, 2018 −$296.43M
Net Income FY 2018 · Dec 31, 2017 −$288.88M
Net Income FY 2018 · Dec 31, 2016 −$156.25M
Operating Income FY 2018 · Dec 31, 2018 −$286.58M
Operating Income FY 2018 · Dec 31, 2017 −$291M
Operating Income FY 2018 · Dec 31, 2016 −$157.86M
Revenue FY 2018 · Dec 31, 2018 $0
Revenue FY 2018 · Dec 31, 2017 $936K
Revenue FY 2018 · Dec 31, 2017 $1.62M
Revenue FY 2018 · Jun 30, 2017 $683K
Revenue FY 2018 · Dec 31, 2016 $113K